Sedentary Lifestyle
Conditions
Keywords
Exercise Therapy, Physical Fitness, Games, Recreational, Children, Adolescents, Healthy Lifestyle, Exercise Test
Brief summary
The purpose of this study is to investigate if playing a newly developed videogame that requires physical activity (e.g. exergame), leads to increased physical activity and health benefits in children and adolescents who do not regularly participate in endurance training. Health benefits will be expressed in physical fitness (maximal oxygen consumption), blood markers of a healthy heart, body composition and objectively measured physical activity. Gaming frequency of the participants will be registered throughout the 24 week intervention period.
Interventions
BEHAVIORALExergaming
free access to the exergaming platform PlayPulse for 24 weeks
Sponsors
Norwegian University of Science and Technology
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
12 Years to 18 Years
Healthy volunteers
No
Inclusion criteria
* Not regularly participating in endurance training * Sedentary (\<60 mins daily moderate/vigorous intensity physical activity) * Play video games \> 10 hours/week (self-reported) * Able to ride a bike for up to 60 minutes
Exclusion criteria
* Known cardiovascular disease * Type I diabetes
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| VO2max | 12 weeks | Maximal Aerobic Capacity |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in daily time in sedentary activity (<3.0 metabolic equivalents =METs) | Baseline, 12 and 24 weeks | Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 12 weeks and 24 weeks. |
| Change in daily time in moderate intensity activity (3.0-6.0 metabolic equivalents = METs) | Baseline, 12 and 24 weeks | Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 12 weeks and 24 weeks. |
| Change in daily time in vigorous intensity activity (6.0-9.0 metabolic equivalents = METs) | Baseline, 12 and 24 weeks | Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 12 weeks and 24 weeks. |
| Change in daily time in very vigorous intensity activity (>9.0 metabolic equivalents = METs) | Baseline, 12 and 24 weeks | Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 12 weeks and 24 weeks. |
| Change in daily average total physical activity duration | Baseline, 12 and 24 weeks | Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 12 weeks and 24 weeks. |
| Change in daily average number of steps | Baseline, 12 and 24 weeks | Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 12 weeks and 24 weeks. |
| Change in daily average energy expenditure | Baseline, 12 and 24 weeks | Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 12 weeks and 24 weeks. |
| systolic Blood Pressure | 12 and 24 weeks | — |
| Diastolic Blood Pressure | 12 and 24 weeks | — |
| Fasting circulating glucose, as blood marker of cardiometabolic health | 24 weeks | — |
| Lipid profile, as blood marker of cardiometabolic health | 24 weeks | — |
| Circulating insulin concentration, as blood marker of cardiometabolic health | 24 weeks | — |
| HbA1c from blood samples | 24 weeks | — |
| Bioelectrical impedance | 12 and 24 weeks | Body composition assessed using bioelectrical impedance analysis (InBody 720) |
Countries
Norway
Outcome results
None listed